发明名称 RIBONUCLEOTIDE REDUCTASE INHIBITORS SENSITIZE TUMOR CELLS TO DNA DAMAGING AGENTS
摘要 The present invention relates to methods for treatment of tumors comprising administering to a subject in need thereof a DNA damaging agent and a ribonucleotide reductase inhibitor. The ribonucleotide reductase inhibitor can sensitize tumor cells to the DNA damaging agent, thus permitting greater treatment efficacy than the DNA damaging agent alone. The methods described herein are generally useful for treating any tumor that can benefit from this combination therapy. In particular, the methods described herein are useful for treating tumors that are resistant or have the propensity to develop resistance to certain DNA damaging agents. Further provided in the prevent invention are compositions comprising a DNA damaging agent and a ribonucleotide reductase inhibitor.
申请公布号 WO2014205179(A1) 申请公布日期 2014.12.24
申请号 WO2014US43119 申请日期 2014.06.19
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 TANNOUS, BAKHOS A.
分类号 A61K45/06 主分类号 A61K45/06
代理机构 代理人
主权项
地址